Skip to main content


US Supreme Court Hears Arguments in Drug Preemption Case

10 November 2008
Mayer Brown Article
Andrew Tauber predicts a narrowly written decision that upholds preemption due to the extent of the questioning on such issues as whether a manufacturer must have new information about risks to change a label unilaterally.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.